semaglutide pdufa date Novo says it's submitted obesity pill for FDA approval Semaglutide Indication Opportunity: From CDK,

Meshkat S, Di Luciano C, Swiderski A, Li G, Aguilar RJ, Dunkley BT, Reichelt AC, Zhang Y, Greenshaw A, Vermetten E, Jetly R, Dash S, Agarwal SM, Swainson J, Bhat V (2025) Efficacy and Safety of Glucagon-Like Peptide-1 Agonists for Psychiatric Symptoms: A Systematic Review

Offering an example of the dangers of contaminated drugs, Young Moss referred to a 2018 incident in which a single compounding pharmacist ignored standard safety procedures and infected 793 patients with fungal meningitis

Diabetes mellitus and impaired pancreatic beta-cell proliferation

It should be used in combination with diet and exercise and is approved for adults with obesity or overweight with at least one weight-related condition